Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC

NCT05798663 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

178

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Atezolizumab
DRUG: Tiragolumab

Sponsor

Alliance Foundation Trials, LLC.

Collaborators

[object Object]